Clinical Guidance

GLP-1 Injection Site Rotation — Why It Matters

May 2025 · 5 min read · Published by WeightWise-UK

If you're taking Mounjaro, Wegovy, Ozempic, or Saxenda, your prescribing clinician will have advised you to rotate injection sites. But why does it matter, and are you doing it correctly? This guide explains the clinical reasoning and gives you a practical rotation schedule to follow.

What Is Injection Site Rotation?

Injection site rotation means systematically changing the location of your subcutaneous injection each week. Rather than always injecting into the same spot, you move to a different area — or a different part of the same region — to allow the tissue to recover fully between injections.

All GLP-1 receptor agonists approved in the UK — including tirzepatide (Mounjaro), semaglutide (Wegovy, Ozempic), and liraglutide (Saxenda) — are administered subcutaneously, meaning into the fatty tissue just beneath the skin. This tissue is susceptible to damage if repeatedly injected in the same spot.

Why Rotation Is Clinically Important

Repeatedly injecting into the same area causes a condition called lipohypertrophy — a build-up of hard, fatty scar tissue beneath the skin. This is well-documented in patients using injectable medications long-term.

Lipohypertrophy matters for several reasons:

  • Unpredictable absorption: Scar tissue absorbs medication at an inconsistent rate, meaning your weekly dose may not work as effectively
  • Reduced efficacy: Studies in insulin-dependent diabetes patients show that injecting into lipohypertrophic tissue significantly reduces drug bioavailability
  • Cosmetic and physical discomfort: Lumps can be visible and tender to touch
  • Progressive worsening: Once formed, lipohypertrophy takes months to resolve — and worsens if you continue injecting in the same area

Approved Injection Sites for GLP-1 Medications

The following sites are approved for subcutaneous GLP-1 injections in the UK:

  • Abdomen: 5cm away from the navel — the most commonly used and generally preferred site
  • Upper thigh (anterior): The front and outer part of the thigh — good alternative, especially if abdominal sensitivity is an issue
  • Upper arm (posterior): The back of the upper arm — often requires assistance for self-injection; avoid the deltoid

Note: Wegovy and Ozempic share the same approved sites as Mounjaro. Saxenda also permits upper arm injections with the same caveats.

A Practical Rotation Schedule

A simple and effective rotation approach for once-weekly GLP-1 injections is to divide each region into quadrants and move systematically through them:

  • Week 1: Right abdomen, upper quadrant
  • Week 2: Left abdomen, upper quadrant
  • Week 3: Right abdomen, lower quadrant
  • Week 4: Left abdomen, lower quadrant
  • Week 5: Right thigh
  • Week 6: Left thigh
  • Then repeat — or incorporate the upper arm if comfortable

Each specific injection should be at least 2–3cm from the previous injection within the same region. Within a single quadrant, vary the exact spot each time.

Sites to Avoid

Always avoid injecting into:

  • Areas that are bruised, swollen, or tender
  • Skin that has scars, stretch marks, or visible lumps
  • The navel area (within 5cm)
  • Moles or broken skin

Tracking Your Sites

Remembering which site you used last week — especially after a few months on treatment — is harder than it sounds. WeightWise-UK's injection tracker includes a body diagram that lets you log and visualise your rotation history, so you always know where to inject next. It's one small habit that protects both your skin and your results.

WeightWise-UK

Track your GLP-1 journey with clinical precision

WeightWise-UK helps you log injections, track weight loss, monitor side effects, and stay on top of your health — all in one place.

Start a free record →